{"name":"Sophiris Bio Corp","slug":"sophiris-bio-corp","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Oncology","slug":"oncology","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"PRX302","genericName":"PRX302","slug":"prx302","indication":"Benign prostatic hyperplasia (BPH)","status":"phase_3"}]},{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"immunology","drugs":[{"name":"PSA-Activated PSA-PAH1","genericName":"PSA-Activated PSA-PAH1","slug":"psa-activated-psa-pah1","indication":"Other","status":"phase_1"}]}],"pipeline":[{"name":"PRX302","genericName":"PRX302","slug":"prx302","phase":"phase_3","mechanism":"PRX302 is a serine protease that selectively activates protease-activated receptor 1 (PAR1) in the prostate to induce localized tissue destruction and immune activation.","indications":["Benign prostatic hyperplasia (BPH)","Prostate cancer (early-stage)"],"catalyst":""},{"name":"PSA-Activated PSA-PAH1","genericName":"PSA-Activated PSA-PAH1","slug":"psa-activated-psa-pah1","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMilgFBVV95cUxPWld1TlNSRmpLNU5XZ09vLVRPNlBRcmR3Q2VyZGZKdEdBZWpMSnFqbkdrQWtOSE5ZZEVEZVJ2bXZQdzR0Q2VLQUx2dVZ5QlpESnlqb0pMbzVWbUU2ZXJDSVJfQzJjSDgtN1NzUzNOQWR6YmFjTHRiOURzMlpLc2pFNDNqaUxEZXFsdjhCa0FYT29DYWpwRnc?oc=5","date":"2026-01-12","type":"pipeline","source":"Clinical Leader","summary":"Working (Well) With Patient Advocates: The Sponsor POV - Clinical Leader","headline":"Working (Well) With Patient Advocates: The Sponsor POV","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiggFBVV95cUxQR01aaVZ5NXJxZ0d4LTNRM0VGR1p0Z3lzeDg4WUxSNFdacEthMnEzLTRJdm9OMXNNLUpLZUhSekMtQlFRdXhudlVsTng4dWQtZlVvTWlKal8tenlqcFd5bXUyekJuYl9zUXJZUlBmVk5XRHh4cFFJelZ6VUVsRjVYQ0pR?oc=5","date":"2025-03-25","type":"pipeline","source":"The Pharma Letter","summary":"Skye Bioscience promotes Tu Diep to COO post - The Pharma Letter","headline":"Skye Bioscience promotes Tu Diep to COO post","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisAFBVV95cUxNbGVsMklucDFKTFNHc0p6ZEppZ1YxVnRDRGhTX1dxekJTTE9hTzJOTWV3UU1kRW5hYS1MTThiMmg4TWQ4Y25YaXNoSU5wdHFQdE9DekFQX0QxNzFDdnY3dTg3N1JyNDUyZVQ4RDBBRkRPWXBsa0RqNE5nYWZsSS1IQnV1dHgxZy1LbWhKczBTc2g2YmJrTWM0Mk1aY2lobmM4YU53amhkMUlVWjB5ajZhUQ?oc=5","date":"2018-06-26","type":"trial","source":"RTTNews","summary":"SPHS Rebounds, ACHV Soars On New Data, PBYI Gains On CHMP Opinion, SPPI Abuzz - RTTNews","headline":"SPHS Rebounds, ACHV Soars On New Data, PBYI Gains On CHMP Opinion, SPPI Abuzz","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiXEFVX3lxTFBkUDlGeDhWX1dzRFJMa2htZG9XSnBIRjFyaVRzOFRVMFlDbUFCUUFMN1BtdHM5ZHQxbmJHTm4tSThBZFJtU1dhUnJNRS1oWkNIT0lfNWxVTXhRVTU4?oc=5","date":"2013-09-22","type":"pipeline","source":"San Diego Business Journal","summary":"Public Performance - San Diego Business Journal","headline":"Public Performance","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihwFBVV95cUxOOWZKQVZsd2pPOG02TGVjRzI1WHJYWW5oUlBvRHFpSlNSZlVkcWI4Z0xqY1JKV0owZGo1dlFkUy1tWjR2dWw4OWlGN3I0TE1zUFNCTVMycFZUdk9PdW1OajRSbDV6dThIb05MQ2NQdExuZmlvUUtZYmxpWlVGbnJJdnRrMW5nc1U?oc=5","date":"2012-10-30","type":"pipeline","source":"Genetic Engineering and Biotechnology News","summary":"The 10 Most Well-Connected People in Biotech - Genetic Engineering and Biotechnology News","headline":"The 10 Most Well-Connected People in Biotech","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiakFVX3lxTE9hbXE5WVJ6WjVvNzVPLTgteTNMSVZmQVZhR1NZNTVMZXR4UHBuRW52bVYyU0wwWWx5Y0N3NTlPNkZ3TUVLc1lUMnRnWl9SLWNDbzBVbDBPVElmSHIwZkNqU0lvOEFQUnVYV1E?oc=5","date":"2012-09-15","type":"pipeline","source":"Genetic Engineering and Biotechnology News","summary":"People in the News - Genetic Engineering and Biotechnology News","headline":"People in the News","sentiment":"neutral"}],"patents":[],"drugCount":2,"phaseCounts":{"phase_3":1,"phase_1":1},"enrichmentLevel":0,"visitCount":3,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}